A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
We are a leading provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Our headquarters are in Waltham, Massachusetts, and we market our products and services in more than 160 countries. As of December 28, 2025, we employed approximately 11,000 employees. Our common stock is listed on the New York Stock Exchange under the symbol “RVTY” and we are a component of the S&P 500 Index. We maintain a website with the address http://www.revvity.com. We are not including the information contained in our website as part of, or incorporating it by reference into, this annual report on Form 10-K.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 2.9B | 2.9B | 2.8B | 3.3B | 3.8B | 3.8B |
| Net Income | 241M | 241M | 270M | 569M | 943M | 728M |
| EPS | $2.07 | $2.07 | $2.20 | $4.50 | $8.08 | $6.49 |
| Free Cash Flow | 509M | 509M | 542M | 594M | 1.3B | 815M |
| ROIC | 3.1% | 3.6% | 3.6% | 5.3% | 8.1% | 8.9% |
| Gross Margin | 60.9% | 60.9% | 62.2% | 65.3% | 52.0% | 70.8% |
| Debt/Equity | 0.55 | 0.55 | 0.43 | 0.60 | 0.78 | 1.59 |
| Dividends/Share | $0.28 | $0.28 | $0.28 | $0.28 | $0.28 | $0.28 |
| Operating Income | 357M | 357M | 347M | 743M | 1.3B | 979M |
| Operating Margin | 12.5% | 12.5% | 12.6% | 22.4% | 32.9% | 25.9% |
| ROE | 3.3% | 3.2% | 3.5% | 7.2% | 13.2% | 19.5% |
| Shares Outstanding | 117M | 117M | 123M | 126M | 117M | 112M |
REVVITY, INC. passes 5 of 9 quality checks, suggesting mixed fundamentals.
REVVITY, INC. trades at 44.8x trailing earnings, compared to its 15-year median P/E of 29.8x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 20.3x vs a median of 25.3x. The company's 5-year average ROIC is 5.9% with a gross margin of 62.2%. Total shareholder yield (dividends + buybacks) is 7.9%. At current prices, the estimated annualized return to fair value is +9.5%.
REVVITY, INC. (RVTY) has a current P/E ratio of 44.8, compared to its historical median P/E of 29.8. The stock is currently considered Expensive based on its historical valuation range.
REVVITY, INC. (RVTY) has a 5-year average return on invested capital (ROIC) of 5.9%. This is below average and may indicate limited pricing power.
REVVITY, INC. (RVTY) has a market capitalization of $10.8B. It is classified as a large-cap stock.
Yes, REVVITY, INC. (RVTY) pays a dividend with a trailing twelve-month yield of 0.30%. The company also returns capital through share buybacks, with a buyback yield of 7.60%.
Based on historical P/E analysis, REVVITY, INC. (RVTY) appears expensive. The current P/E of 44.8 is 50% above its historical median of 29.8. The estimated fair value CAGR (P/E method) is 7.5%.
REVVITY, INC. (RVTY) operates in the Laboratory Analytical Instruments industry, within the Technology sector.
REVVITY, INC. (RVTY) reported annual revenue of $2.9 billion in its most recent fiscal year, based on SEC EDGAR filings.
REVVITY, INC. (RVTY) has a net profit margin of 8.4%. This is a modest margin.
REVVITY, INC. (RVTY) generated $509 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
REVVITY, INC. (RVTY) has a debt-to-equity ratio of 0.55. This indicates moderate leverage.
REVVITY, INC. (RVTY) reported earnings per share (EPS) of $2.07 in its most recent fiscal year.
REVVITY, INC. (RVTY) has a return on equity (ROE) of 3.2%. This indicates moderate shareholder returns.
REVVITY, INC. (RVTY) has a 5-year average gross margin of 62.2%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 17 years of financial data for REVVITY, INC. (RVTY), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
REVVITY, INC. (RVTY) has a book value per share of $62.22, based on its most recent annual SEC filing.